This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tadmori, W Articles by Prakash, O Search for Related Content PubMed PubMed Citation Articles by Tadmori, W Articles by Prakash, O

 Previous Article  |  Next Article 

J Virol. 1991 December; 65(12): 6425-6429

Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha.

Department of Molecular Oncology, Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121.

ABSTRACT

Tumor necrosis factor alpha (TNF-alpha) is expressed in secreted and cell surface (csTNF-alpha) forms by activated monocytic and T cells. In this report, we demonstrate that csTNF-alpha may predominantly regulate the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) activation in the promonocytic cell line U937 and in the Epstein-Barr virus-transformed B-cell line BH1. Anti-TNF-alpha antibody suppressed both the constitutive expression of the HIV-1 LTR in BH1 cells and the expression induced by phorbol 12-myristate 13-acetate in U937 cells. This suppression was found to be mediated via csTNF-alpha. No correlation between the HIV-1 LTR activation and the secretion of TNF-alpha was evident in these cell lines. Suppression of TNF-alpha secretion by cyclosporin A or by a serine protease inhibitor did not suppress the HIV-1 LTR activation. These observations suggest a novel biological role for csTNF-alpha in the immunopathogenesis of AIDS.

This article has been cited by other articles:

• Israel-Biet, D, Esvant, H, Laval, A M, Cadranel, J (2004). Impairment of {beta} chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia. Thorax 59: 247-251 [Abstract] [Full Text]  
• Kacani, L., Banki, Z., Zwirner, J., Schennach, H., Bajtay, Z., Erdei, A., Stoiber, H., Dierich, M. P. (2001). C5a and C5adesArg Enhance the Susceptibility of Monocyte-Derived Macrophages to HIV Infection. J. Immunol. 166: 3410-3415 [Abstract] [Full Text]  
• Weiden, M., Tanaka, N., Qiao, Y., Zhao, B. Y., Honda, Y., Nakata, K., Canova, A., Levy, D. E., Rom, W. N., Pine, R. (2000). Differentiation of Monocytes to Macrophages Switches the Mycobacterium tuberculosis Effect on HIV-1 Replication from Stimulation to Inhibition: Modulation of Interferon Response and CCAAT/Enhancer Binding Protein {beta} Expression. J. Immunol. 165: 2028-2039 [Abstract] [Full Text]  
• Casoli, C., Vicenzi, E., Cimarelli, A., Magnani, G., Ciancianaini, P., Cattaneo, E., Dall'Aglio, P., Poli, G., Bertazzoni, U. (2000). HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha. Blood 95: 2760-2769 [Abstract] [Full Text]  
• Honda, Y., Rogers, L., Nakata, K., Zhao, B.-Y., Pine, R., Nakai, Y., Kurosu, K., Rom, W. N., Weiden, M. (1998). Type I Interferon Induces Inhibitory 16-kD CCAAT/ Enhancer Binding Protein (C/EBP)beta , Repressing the HIV-1 Long Terminal Repeat in Macrophages: Pulmonary Tuberculosis Alters C/EBP Expression, Enhancing HIV-1 Replication. J. Exp. Med. 188: 1255-1265 [Abstract] [Full Text]  
• Fauci, A. (1993). Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262: 1011-1018 [Abstract]